Skip to main content

For the record: Wilson’s insurtech Abacai acquires Dayinsure; 250 job losses at BGL; GRS recruits Advanta team; and Howden acquires STA Group

For the record

Post wraps up the major insurance deals, launches, investments and strategic moves of the week not covered elsewhere on www.postonline.co.uk

Abacai acquires Dayinsure

Date announced: 8 March

Deal value: Undisclosed

Abacai Group, the insurtech recently formed by Mark Wilson and Sun Capital Partners, has announced the acquisition of

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Acrisure blames AI for slashing 2250 jobs

Acrisure is cutting around 11% of its global workforce, after chief executive and co-founder Greg Williams told staff advances in artificial intelligence and technology are reshaping how the business operates and serves clients.

Howden launches Web3 risk ecosystem

The broking group has expanded its crypto theft insurance product, bringing together specialist vendors across pre-emptive risk management and post-incident recovery.

TimeTo: Reflect on the 2026 Biba Conference

Content Director’s View: This week a swathe of the UK general insurance sector decamped to Manchester for the annual British Insurance Brokers’ Association conference. Jonathan Swift reflects on some of the themes and talking points of the 2026 iteration.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here